DCF — THE QUEENS MEDICAL CENTER
Enterprise Value: $-144.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-144.5M
Enterprise Value
$-82.2M
PV of Cash Flows
$-62.3M
PV of Terminal Value
$-100.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.5B | $21.5M | 1.0% | $-40.6M | $-36.9M |
| Year 2 | $1.5B | $37.3M | 2.0% | $-26.7M | $-22.1M |
| Year 3 | $1.6B | $54.0M | 3.0% | $-15.7M | $-11.8M |
| Year 4 | $1.6B | $63.6M | 4.0% | $-10.1M | $-6.9M |
| Year 5 | $1.7B | $69.7M | 4.0% | $-7.3M | $-4.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-144.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.009680649945835278
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5